Herbesan Aubier du Tilleul bio
Food supplement declared in France, declaration No 2016-10-556
Herbesan Aubier du Tilleul bio (Herbesan) is a food supplement declared in France. Status: withdrawn from the market on 19 June 2026. None of the rules we check flags an issue with its declared composition.
- Brand
- Herbesan
- Food business operator placing the product on the market
- LABORATOIRES SUPER DIET
- Status
- Withdrawn from the market on 19 June 2026
- Form
- Ampoule
- Daily dose
- 1 ampoule
- Directions for use
- pure ou diluée dans un verre d'eau
- Not recommended (according to the manufacturer)
- Breastfeeding women, Pregnant women
- Objectives stated by the manufacturer (these are not authorised claims)
- Digestion
Declaration 276639, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Tilia platyphyllos Scop. | Aubier | Extrait fluide aqueux | 600 mg |
| Tilia cordata Mill. | Aubier | Extrait fluide aqueux | 600 mg |
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Regulatory points
- Information
Withdrawn from the market on 19 June 2026, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Tilia platyphyllos Scop.
Read the warning, when it applies and the studies cited
Linden - TILIA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Mills and Bone 2005; De Smet 1993).
Sources cited by Health Canada (2)
- De Smet PAGM, Keller K, Hansel R, Chandler RF, editors. Adverse Effects of Herbal Drugs, Volume 2. Berlin (DE): Springer-Verlag; 1993.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
- Tilia cordata Mill.
Read the warning, when it applies and the studies cited
Linden - TILIA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Mills and Bone 2005; De Smet 1993).
Sources cited by Health Canada (2)
- De Smet PAGM, Keller K, Hansel R, Chandler RF, editors. Adverse Effects of Herbal Drugs, Volume 2. Berlin (DE): Springer-Verlag; 1993.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : Herbesan
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.